Literature DB >> 16792005

Esophageal cancer staging: the role of radiology.

Francesco Maria Caputo1, Grazia Loretta Buquicchio.   

Abstract

In esophageal cancer staging, the radiologic approach is represented by tumor identification, preoperative staging, and re-staging after neoadjuvant therapies. At present, while barium radiography shows a high sensitivity for early and advanced tumors, endoscopy is always necessary for confirmation. CT and MRI are the gold standard for preoperative staging of advanced (T4) esophageal cancer and for evaluation of distant metastasis; however they still show a low sensitivity in the study of possible regional lymph node involvement, in differentiating residual disease and scarring; in particular the esophageal wall cannot be carefully examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16792005

Source DB:  PubMed          Journal:  Rays        ISSN: 0390-7740


  4 in total

Review 1.  [Oesophageal tumours--what does the surgeon need from the radiologist?].

Authors:  H Feussner; M Feith
Journal:  Radiologe       Date:  2007-02       Impact factor: 0.635

2.  Prognostic significance of endoscopic ultrasound-defined pleural, pericardial or peritoneal fluid in oesophageal cancer.

Authors:  Christopher P Twine; Jonathan D Barry; Guy R J Blackshaw; Tom D Crosby; S Ashley Roberts; Wyn G Lewis
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

3.  Superficial esophageal lesions detected by endoscopic ultrasound enhanced with submucosal edema.

Authors:  Jian-Jun Li; Long-Jun He; Hong-Bo Shan; Thomas D Wang; Huan Xiong; Li-Ming Chen; Guo-Liang Xu; Xiao-Hai Li; Xin-Xin Huang; Guang-Yu Luo; Yin Li; Rong Zhang
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

4.  Inter-Observer and Intra-Observer Variability in Gross Tumor Volume Delineation of Primary Esophageal Carcinomas Based on Different Combinations of Diagnostic Multimodal Images.

Authors:  Fengxiang Li; Yankang Li; Xue Wang; Yingjie Zhang; Xijun Liu; Shanshan Liu; Wei Wang; Jinzhi Wang; Yanluan Guo; Min Xu; Jianbin Li
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.